Combined therapy using LHRH-PE40 and anti-CD40 dendritic cells substantially eliminate tumor cells

Zhang, LM; Du, TJ; Ma, DB; Guo, F; Li, ZW; Yan, H

Yan, H (reprint author), Tianjin Huanhu Hosp, 6 Jizhao Rd, Tianjin 300000, Peoples R China.

JOURNAL OF CELLULAR BIOCHEMISTRY, 2019; 120 (5): 8093

Abstract

LHRH-PE40 was used to promote the proliferation of bone marrow derived cell (BMDC) and improve the antigen-presenting ability of BMDC as well as the i......

Full Text Link